Table 2.
Summary of the main results at univariate analysis.
Variable | Hospital admission for COVID-19 related reasons | Complicated SARS-CoV-2 infection | Ventilatory support | ICU admission | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Yes | No | p | Yes | No | p | Yes | No | p | Yes | No | p | |
Age (median) | 5.8 | 8.6 | <0.001 | 7.2 | 7.3 | 0.86 | 6.6 | 7.4 | 0.38 | 7.7 | 7.3 | 0.68 |
Age group | ||||||||||||
<1year | 117 | 38 | <0.001 | 35 | 125 | 0.83 | 12 | 148 | 0.25 | 5 | 155 | |
1–4 years | 80 | 78 | 32 | 128 | 8 | 152 | 2 | 158 | ||||
5–9 years | 63 | 87 | 30 | 125 | 13 | 142 | 11 | 144 | 0.039 | |||
>10 years | 101 | 168 | 52 | 232 | 12 | 272 | 9 | 275 | ||||
Demographics | ||||||||||||
Male gender | 207 | 205 | 0.57 | 83 | 343 | 0.9 | 26 | 400 | 0.81 | 16 | 410 | 0.73 |
Underlying clinical conditions | 80 | 50 | <0.001 | 47 | 89 | <0.001 | 23 | 113 | <0.001 | 14 | 122 | <0.001 |
Immunosuppression | 13 | 4 | 0.021 | 4 | 13 | 0.68 | 0 | 17 | 0.29 | 1 | 16 | 0.6 |
None/only one infected family member | 217 | 153 | <0.001 | 104 | 279 | <0.001 | 39 | 344 | <0.001 | 23 | 360 | <0.001 |
Clinical manifestations | ||||||||||||
Fever | 292 | 247 | <0.001 | 125 | 422 | <0.001 | 40 | 507 | 0.01 | 25 | 522 | 0.016 |
Abdominal pain | 32 | 18 | 0.026 | 24 | 28 | <0.001 | 7 | 45 | 0.017 | 4 | 48 | 0.095 |
Laboratory results | ||||||||||||
Leukocytosis | 65 | 8 | 0.024 | 44 | 34 | <0.001 | 18 | 60 | <0.001 | 11 | 67 | 0.001 |
Lymphopenia | 65 | 16 | 0.8 | 46 | 36 | <0.001 | 20 | 62 | <0.001 | 19 | 63 | <0.001 |
Viral coinfection | 44 | 1 | 0.016 | 21 | 24 | 0.87 | 13 | 32 | 0.015 | 8 | 37 | 0.009 |
ICU, intensive care unit. Bold values are statistically significant.